Beta-lactamase in gram-negative rods: the relationship between penicillinase and R plasmids in gram-negative rods. 1990

Y Takesue, and T Yokoyama, and T Kodama, and Y Murakami, and H Sewake, and K Miyamoto, and Y Imamura, and H Tsumura, and Y Matsuura
First Department of Surgery, Hiroshima University School of Medicine, Japan.

Concomitant with the extensive use of antibiotics, the number of multiple antibiotic-resistant strains has been increasing. Since resistance is mainly mediated by R plasmids, we undertook to investigate the characteristics of R plasmid-determined beta-lactamase in 6 Gram-negative rods. The beta-lactamase produced by each organism was classified by its substrate: type P which attacks penicillins, type C which attacks cephalosporins, and type C/P which attacks both penicillins and cephalosporins. Though the chromosomally mediated beta-lactamase of almost all Gram-negative rods is classified as type C, R plasmid-mediated beta-lactamase is almost equally active against both penicillins and cephalosporins. Therefore, we suggest that type C/P beta-lactamase was mediated by R plasmids in Gram-negative rods which already produced chromosomally mediated type C beta-lactamase. The strains which produced type C/P beta-lactamase tended to be more resistant to antibiotics than the other beta-lactamase producing strains. Among type C/P strains, the sensitivity to cephalosporins varied with the bacterial species, whereas all these strains were highly resistant to penicillins. Even for piperacillin, which is stable to cephalosporinase, the MIC at which the cumulative percentage of strains inhibited was 50% (MIC50) was over 50 micrograms/ml in all strains tested.

UI MeSH Term Description Entries
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D009070 Moxalactam Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections. 1-Oxacephalosporin,6059-S,Disodium Latamoxef,Disodium Moxalactam,Festamoxin,Lamoxactam,Latamoxef,Lilly 127935,Ly-127935,Ly127935,Moxalactam Disodium,S-6059,Shiomarin,1 Oxacephalosporin,6059 S,6059S,Disodium, Moxalactam,Latamoxef, Disodium,Ly 127935,Moxalactam, Disodium,S 6059,S6059
D010400 Penicillin G A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission. Benzylpenicillin,Benpen,Benzylpenicillin Potassium,Coliriocilina,Crystapen,Or-pen,Parcillin,Pekamin,Pengesod,Penibiot,Penicilina G Llorente,Penicillin G Jenapharm,Penicillin G Potassium,Penicillin G Sodium,Penicillin Grünenthal,Penilevel,Peniroger,Pfizerpen,Sodiopen,Sodipen,Sodium Benzylpenicillin,Sodium Penicillin,Unicilina,Ursopen,Van-Pen-G
D010405 Penicillinase A beta-lactamase preferentially cleaving penicillins. (Dorland, 28th ed) EC 3.5.2.-. beta-Lactamase I,AER-I beta-Lactamase,Benzylpenicillinase,Carbenicillinase,Exopenicillinase,beta Lactamase III,beta Lactamase RP4,gamma-Penicillinase,AER I beta Lactamase,Lactamase RP4, beta,beta Lactamase I,beta-Lactamase, AER-I,gamma Penicillinase
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011815 R Factors A class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation. R Factor,R Plasmid,R Plasmids,Resistance Factor,Resistance Factors,Factor, R,Factor, Resistance,Factors, R,Factors, Resistance,Plasmid, R,Plasmids, R
D002437 Cefazolin A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. Cephazolin,Ancef,Cefamedin,Cefamezine,Cefazolin Sodium,Cephamezine,Cephazolin Sodium,Gramaxin,Kefzol,Sodium Cephazolin,Totacef,Cephazolin, Sodium,Sodium, Cefazolin,Sodium, Cephazolin
D002438 Cefoperazone Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections. Cefobid,Cefoperazon,Cefoperazone Sodium,Cefoperazone Sodium Salt,Céfobis,T-1551,T1551,Salt, Cefoperazone Sodium,Sodium Salt, Cefoperazone,Sodium, Cefoperazone,T 1551
D002510 Cephalosporinase beta-Lactamase II,Cephalexin Amidase,Cephalosporin Amido-beta-Lactam Hydrolase,Cephalosporin beta-Lactamase,Amidase, Cephalexin,Amido-beta-Lactam Hydrolase, Cephalosporin,Cephalosporin Amido beta Lactam Hydrolase,Cephalosporin beta Lactamase,Hydrolase, Cephalosporin Amido-beta-Lactam,beta Lactamase II,beta-Lactamase, Cephalosporin
D002954 Citrobacter A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon.

Related Publications

Y Takesue, and T Yokoyama, and T Kodama, and Y Murakami, and H Sewake, and K Miyamoto, and Y Imamura, and H Tsumura, and Y Matsuura
January 1999, Ryoikibetsu shokogun shirizu,
Y Takesue, and T Yokoyama, and T Kodama, and Y Murakami, and H Sewake, and K Miyamoto, and Y Imamura, and H Tsumura, and Y Matsuura
January 1999, Ryoikibetsu shokogun shirizu,
Y Takesue, and T Yokoyama, and T Kodama, and Y Murakami, and H Sewake, and K Miyamoto, and Y Imamura, and H Tsumura, and Y Matsuura
June 1979, Journal of bacteriology,
Y Takesue, and T Yokoyama, and T Kodama, and Y Murakami, and H Sewake, and K Miyamoto, and Y Imamura, and H Tsumura, and Y Matsuura
August 1987, European journal of clinical microbiology,
Y Takesue, and T Yokoyama, and T Kodama, and Y Murakami, and H Sewake, and K Miyamoto, and Y Imamura, and H Tsumura, and Y Matsuura
January 2005, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Y Takesue, and T Yokoyama, and T Kodama, and Y Murakami, and H Sewake, and K Miyamoto, and Y Imamura, and H Tsumura, and Y Matsuura
October 1986, FEBS letters,
Y Takesue, and T Yokoyama, and T Kodama, and Y Murakami, and H Sewake, and K Miyamoto, and Y Imamura, and H Tsumura, and Y Matsuura
January 1990, Chemotherapy,
Y Takesue, and T Yokoyama, and T Kodama, and Y Murakami, and H Sewake, and K Miyamoto, and Y Imamura, and H Tsumura, and Y Matsuura
July 1971, The Biochemical journal,
Y Takesue, and T Yokoyama, and T Kodama, and Y Murakami, and H Sewake, and K Miyamoto, and Y Imamura, and H Tsumura, and Y Matsuura
January 2002, Medycyna doswiadczalna i mikrobiologia,
Y Takesue, and T Yokoyama, and T Kodama, and Y Murakami, and H Sewake, and K Miyamoto, and Y Imamura, and H Tsumura, and Y Matsuura
May 2013, Journal of infection in developing countries,
Copied contents to your clipboard!